1. Home
  2. GLP vs SVRA Comparison

GLP vs SVRA Comparison

Compare GLP & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Partners LP

GLP

Global Partners LP

HOLD

Current Price

$42.33

Market Cap

1.5B

Sector

Energy

ML Signal

HOLD

SVRA

Savara Inc.

HOLD

Current Price

$5.69

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLP
SVRA
Founded
2005
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.2B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
GLP
SVRA
Price
$42.33
$5.69
Analyst Decision
Hold
Buy
Analyst Count
1
9
Target Price
$45.00
$7.33
AVG Volume (30 Days)
52.4K
3.7M
Earning Date
11-07-2025
11-12-2025
Dividend Yield
7.22%
N/A
EPS Growth
N/A
N/A
EPS
2.08
N/A
Revenue
$18,099,776,000.00
N/A
Revenue This Year
$22.70
N/A
Revenue Next Year
$42.12
N/A
P/E Ratio
$20.11
N/A
Revenue Growth
4.10
N/A
52 Week Low
$39.70
$1.89
52 Week High
$60.00
$7.01

Technical Indicators

Market Signals
Indicator
GLP
SVRA
Relative Strength Index (RSI) 43.37 43.55
Support Level $41.53 $6.25
Resistance Level $43.00 $6.64
Average True Range (ATR) 1.22 0.36
MACD -0.08 -0.15
Stochastic Oscillator 23.54 7.99

Price Performance

Historical Comparison
GLP
SVRA

About GLP Global Partners LP

Global Partners LP is a limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the Wholesale segment.

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

Share on Social Networks: